+

WO2003004066A1 - Agents therapeutiques genetiques - Google Patents

Agents therapeutiques genetiques Download PDF

Info

Publication number
WO2003004066A1
WO2003004066A1 PCT/JP2002/006772 JP0206772W WO03004066A1 WO 2003004066 A1 WO2003004066 A1 WO 2003004066A1 JP 0206772 W JP0206772 W JP 0206772W WO 03004066 A1 WO03004066 A1 WO 03004066A1
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
gene therapeutics
amino acid
acid sequence
activity
Prior art date
Application number
PCT/JP2002/006772
Other languages
English (en)
Japanese (ja)
Inventor
Keiji Tanaka
Hideto Chono
Mio Morishita
Haruko Konishi
Mitsuhiro Ueno
Kiyozo Asada
Ikunoshin Kato
Original Assignee
Takara Bio Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Bio Inc. filed Critical Takara Bio Inc.
Publication of WO2003004066A1 publication Critical patent/WO2003004066A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne des médicaments contenant un gène qui code un polypeptide comportant la séquence d'acides aminés d'un polypeptide présentant une activité d'adhérence cellulaire et la séquence d'acides aminés d'un polypeptide présentant une activité de facteur de croissance des fibroblastes.
PCT/JP2002/006772 2001-07-05 2002-07-04 Agents therapeutiques genetiques WO2003004066A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-204300 2001-07-05
JP2001204300A JP2005052001A (ja) 2001-07-05 2001-07-05 遺伝子治療剤

Publications (1)

Publication Number Publication Date
WO2003004066A1 true WO2003004066A1 (fr) 2003-01-16

Family

ID=19040794

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/006772 WO2003004066A1 (fr) 2001-07-05 2002-07-04 Agents therapeutiques genetiques

Country Status (2)

Country Link
JP (1) JP2005052001A (fr)
WO (1) WO2003004066A1 (fr)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
US5049658A (en) * 1988-01-05 1991-09-17 Takara Shuzo Co., Ltd. Polypeptide with cell-spreading activity
JPH03232898A (ja) * 1990-02-05 1991-10-16 Takara Shuzo Co Ltd 機能性ポリペプチド
JPH03284700A (ja) * 1990-03-30 1991-12-16 Takara Shuzo Co Ltd 機能性ポリペプチド
US5302701A (en) * 1991-10-14 1994-04-12 Takara Shuzo Co., Ltd. Polypeptide having human fibronectin-like cell adhesive activity
WO1995003831A1 (fr) * 1993-08-02 1995-02-09 Prizm Pharmaceuticals, Inc. Preparations monogenes de conjugues cytotoxiques
WO1997018318A1 (fr) * 1995-11-13 1997-05-22 Takara Shuzo Co., Ltd. Procede d'introduction de genes dans des cellules cibles au moyen de retrovirus
JPH1029952A (ja) * 1996-07-16 1998-02-03 Takara Shuzo Co Ltd ヒト免疫不全ウイルス感染の制御用組成物および制御方法
WO1999040945A2 (fr) * 1998-02-11 1999-08-19 The Regents Of The University Of California Traitement de l'angiogenese par transfert de genes et techniques d'apport intravasculaire de genes
WO1999055861A2 (fr) * 1998-04-28 1999-11-04 Eisai Co., Ltd. Compositions de muteine du facteur de croissance de fibroblastes et procedes d'utilisation associes
WO2000001836A1 (fr) * 1998-07-01 2000-01-13 Takara Shuzo Co., Ltd. Procedes de transfert de genes

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026839A (en) * 1985-12-17 1991-06-25 Synergen, Inc DNA encoding a basic fibroblast growth factor
US5049658A (en) * 1988-01-05 1991-09-17 Takara Shuzo Co., Ltd. Polypeptide with cell-spreading activity
JPH03232898A (ja) * 1990-02-05 1991-10-16 Takara Shuzo Co Ltd 機能性ポリペプチド
JPH03284700A (ja) * 1990-03-30 1991-12-16 Takara Shuzo Co Ltd 機能性ポリペプチド
US5302701A (en) * 1991-10-14 1994-04-12 Takara Shuzo Co., Ltd. Polypeptide having human fibronectin-like cell adhesive activity
WO1995003831A1 (fr) * 1993-08-02 1995-02-09 Prizm Pharmaceuticals, Inc. Preparations monogenes de conjugues cytotoxiques
WO1997018318A1 (fr) * 1995-11-13 1997-05-22 Takara Shuzo Co., Ltd. Procede d'introduction de genes dans des cellules cibles au moyen de retrovirus
JPH1029952A (ja) * 1996-07-16 1998-02-03 Takara Shuzo Co Ltd ヒト免疫不全ウイルス感染の制御用組成物および制御方法
WO1999040945A2 (fr) * 1998-02-11 1999-08-19 The Regents Of The University Of California Traitement de l'angiogenese par transfert de genes et techniques d'apport intravasculaire de genes
WO1999055861A2 (fr) * 1998-04-28 1999-11-04 Eisai Co., Ltd. Compositions de muteine du facteur de croissance de fibroblastes et procedes d'utilisation associes
WO2000001836A1 (fr) * 1998-07-01 2000-01-13 Takara Shuzo Co., Ltd. Procedes de transfert de genes

Also Published As

Publication number Publication date
JP2005052001A (ja) 2005-03-03

Similar Documents

Publication Publication Date Title
WO2004043382A3 (fr) Variants ameliores de l'erythropoietine et methodes d'utilisation
AU7368100A (en) Fibroblast growth factor polypeptide and nucleic acids encoding same
AU2003256050A1 (en) Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
AU4697396A (en) Peptide, peptide analog and amino acid analog protease inibitors
WO2005016283A3 (fr) Peptides pour ameliorer l'attachement et la croissance de cellules
WO1998051799A1 (fr) Nouvel inhibiteur de differentiation
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
AU2002236300A1 (en) Novel protein, gene encoding the same and method of using the same
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
CA2281206A1 (fr) Genes de geranyl diphosphate synthase
WO2003004066A1 (fr) Agents therapeutiques genetiques
AU1509501A (en) A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide
WO2004096833A3 (fr) Inducteurs d'expression de proteine de recombinaison
AU2003264535A1 (en) Tumor antigen protein and utilization thereof
DE60130922D1 (de) Peptide mit inhibierender Aktivität zur Produktion von Stickstoffmonoxid
AU2003220146A1 (en) Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof
WO2007073845A8 (fr) Nouveau polypeptide presentant une activite d'esterase, esterase recombinee et leur utilisation
AU2003295435A1 (en) Biological carriers for the delivery of proteins or peptides
WO2001087932A3 (fr) Sept protéines transmembranaires et polynucléotides les codant
WO2001029084A3 (fr) Nouvelles proteines humaines et polynucleotides codant pour ces memes proteines
WO1996038556A3 (fr) Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse
AU784169C (en) Homeobox gene encoding a protein involved in differentiation
WO2003018806A1 (fr) Nouveau gene humain bmcc1
AU6679498A (en) A novel bak binding protein, dna encoding the protein, and methods of use thereof
EP1427825B8 (fr) Adnc codant pour la sous-unite humaine de canal calcique alpha2 delta4

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载